Abstract
Because of the inverse association of cigarette smoking with the risk of Parkinson's disease, we performed a short-term, double-blind, randomized controlled trial of nicotine polacrilex resin gum in patients with this disease. Forty-eight subjects were randomly assigned to chew either nicotine gum or placebo gum three times at 2-h intervals, with evaluation of symptoms before and after the trial. The nicotine gum was reasonably well tolerated, but there were no substantial differences in Parkinson's disease symptoms between the two treatment groups.
Article PDF
Avoid common mistakes on your manuscript.
References
Baron JA (1986) Cigarette smoking and Parkinson's disease. Neurology 36:1490–1496
Behmand RA, Harik SI (1992) Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. J Neurochem 58:776–779
Brogden RN, Speight TM, Avery GS (1971) Levadopa: a review of its pharmacological properties and therapeutic uses with particular reference to parkinsonism. Drugs 2:262–400
Carr LA, Basham JK, York BK, Rowell PP (1992) Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components. Eur J Pharmacol 215:285–287
Cotzias GC, Van Woert MH, Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. New Engl J Med 276:374–379
Fagerström KO, Pomerlean O, Giordani B, Stelson F (1994) Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 116:117–119
Fahn S, Bressman SB (1984) Should levodopa therapy for parkinsonism be started early or late? Evidence against early treatment. Can J Neurol Sci 11:200–206
Fehling C (1966) Treatment of Parkinson's syndrome with L-dopa: a double blind study. Acta Neurol Scand 42:367–372
Fung YK, Fiske LA, Yuen-Sum L (1991) Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice. Gen Pharmacol 22:669–672
Fuxe K, Agnatic L, Eneroth P, Gustafsson J-Å, Hökfelt T, Löfström A, Skett B, Skett P (1977) The effect of nicotine on central catecholamine neurons and gonadotropin secretion. I. Studies in the male rat. Med Biol 55:148–157
Ishikawa A, Miyatake T (1993) Effects of smoking in patients with early-onset Parkinson's disease. J Neurol Sci 117:28–32
Janson AM, Fuxe K, Agnati LF, Kitayama I, Harfstrand A, Andersson K, Goldstein M (1988) Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal system of the male rat after partial hemitransection. Brain Res 455:332–345
Kaakkola S (1981) Effect of nicotinic and muscarinic drugs on amphetamine- and apomorphine-induced circling behavior in rats. Acta Pharmacol Toxicol 48:162–167
Lang AET, Fahn S (1989) Assessment of Parkinson's disease. In: Munsat TL (ed) Quantification of neurologic deficit. Butterworths, Boston, pp 285–309
Lapin EP, Maker HS, Sershen H, Hurd Y, Lajtha A (1987) Dopamine-like action of nicotine: lack of tolerance and reverse tolerance. Brain Res 407:351–363
Lichtensteiger W, Felix D, Hefti F, Schlumpf M (1979) Effects of nicotine on dompaminergic neurones of adult and prenatal mammals and of invertebrates. In: Remond A, Izard C (eds) Electrophysiological effects of nicotine. Elsevier/North-Holland, Amsterdam
Marshall J, Schnieden H (1966) Effect of adrenaline, noradrenaline, atropine and nicotine on some types of human tremor. J Neurol Neurosurg Psychiatry 29:214–218
Moll H (1926) The treatment of post-encephalitic parkinsonism by nicotine. BMJ 1:1079–1081
Owman Ch, Fuxe K, Janson AM, Kahrstrom J (1989) Chronic nicotine treatment eliminates asymmetry in striatal glucose utilization following unilateral transection of the mesostriatal dopamine pathway in rats. Neurosci Lett 102:279–283
Perry TL, Hansen S, Jones K (1987) Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Neurosci Lett 74:217–220
Sershen H, Lajtha A (1979) Cerebral uptake of nicotine and of amino acids. J Neurosci Res 4:85–89
Sershen H, Hashim A, Wiener HL, Lajtha A (1988) Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse. Neurosci Lett 93:270–274
Shahi GS, Moochhala SM, Das NP (1990) The association between smoking and Parkinson's disease: new insights from studies using the mouse MPTP model. Eur J Pharmacol 183:1100–1101
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clemens, P., Baron, J.A., Coffey, D. et al. The short-term effect of nicotine chewing gum in patients with parkinson's disease. Psychopharmacology 117, 253–256 (1995). https://doi.org/10.1007/BF02245195
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245195